Short interest in Mineralys Therapeutics Inc (NASDAQ:MLYS) decreased during the last reporting period, falling from 1.56M to 1.47M. This put 4.33% of the company's publicly available shares short.

Short interest for Mineralys Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Mineralys Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 96.77K shares traded per day, it would take 15.21 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.